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1. INTRODUCTION & AIM
Pediatric drug researchers are confronted with several ethical
problems because they have to balance the rights and interests of
the participating children and parents with societal interests and
scientific demands. Much has been written about the ethics of
designing pediatric studies, but little is known about the
experiences and ethical decision making of researchers when a trial
is already running.
The goal of this local survey was to gain more insight in the way
researchers experience the practical and ethical challenges of
pediatric clinical trials. We aim to describe some of the tensions and
difficulties that researchers have to deal with and to make some
practical suggestions about how to handle these issues.
Informed consent has been a core issue in the ethics of pediatric
clinical trials. Additionally, we focused on the start-up and actual
conducting phases of trials to be able to paint a picture of the
context within which pediatric clinical trials are being performed.
2. METHODS
A questionnaire was sent out to 67 researchers from every sub
specialty within the Princess Elisabeth Children's Hospital, Ghent
University Hospital (Belgium). We received 27 questionnaires, a
response rate of 40%. The questionnaire was completed by 19
physicians, 6 study nurses, one pharmacist and one clinical trial
coordinator. The participants spent an average of 49 hours per
month (range 1-140) on research.
Participants were asked to rate a series of issues regarding pediatric
clinical trials on a scale from 1 to 5 where 1 meant ‘not problematic’
and 5 meant ‘highly problematic’. At the end of each series,
participants were given the opportunity to write down extra
comments. The results can be interpreted very negatively, because
every category from 2-5 implies that there is some kind of problem.
However, small problems will always occur in practice, but they
should be easily manageable. Therefore, we analyzed the data
similarly to Likert scale data to distinguish between minor issues and
structural problems.
3. RESULTS
The participants were confident in their ability to obtain informed
consent. The problems they reported all pertain to external factors
like availability of both parents, time and stressful environment.
Several study nurses remarked that they should be allowed to be
more actively involved in the informed consent process.
The participants experienced many problems during the start-up of
pediatric clinical trials. The two biggest issues are work load and the
time it takes to start up a trial, but a lot of participants experience
serious issues with every aspect we questioned except for
communication.
4. CONCLUSIONS & DISCUSSION
• A general theme in the survey was time management. Most
researchers combine research with clinical care and other duties, which
means that at critical times like the start-up, performing clinical trials can
be very burdensome.
• Physicians reported to be very confident about their communication
skills and their ability to manage the trust relationship with patients and
to explain the informed consent form.
•Pediatric studies will often run parallel without much interaction
because of the fragmented nature of a pediatric clinic where very
different subspecialties are represented. This explains why visibility and
awareness of studies was experienced as highly problematic.
 Pediatric research is best conducted in a general center of excellence
instead of on independent islands. This will diminish some of the most
serious issues that were identified in the data: more visibility, better
management of workloads, stronger positions in budget negotiations,
dedicated research staff and creating a better environment for
informed consent. A research center can also provide support with
fundraising, help with IRB submission, coordinate service departments
within the hospital and manage multicenter studies better.
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With regard to conducting a trial, the most problems were reported 
concerning visibility, work load and a lack of suitable participants. Especially 
concerning visibility, defined as the awareness about trials run by colleagues 
and actively recruiting for these trials, it is worth noting that every 
participant indicated that there is a problem. 
Some people used the extra comments section to remark that clinical trials 
have a bad name on the work floor. They are seen as unnecessary extra 
work, especially among nursing staff with no direct affiliation to research.
